Davis Aaron I.

Avg. Two Year Performance

< 1% Avg. Purchase Return
0% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return3%4%5%6%< 1%
Purchase Success Rate2 of 42 of 41 of 41 of 41 of 4
Average Sale Return(23%)(27%)(61%)(57%)0%
Sale Success Rate0 of 20 of 20 of 20 of 20 of 2

Odonate Therapeutics, Inc.

Other » Other

Director, 10% Owner:

Holdings: 5.05M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Mirati Therapeutics, Inc.

Drugs » Biotechnology

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Iteos Therapeutics, Inc.

Other » Other

Director:

Holdings: 2.15M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Rain Oncology Inc.

Other » Other

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Tango Therapeutics, Inc.

Other » Other

:

Holdings: 14.39M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--